Review



hy 13782 tenofovir alafenamide taf medchemexpress  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress hy 13782 tenofovir alafenamide taf medchemexpress
    Hy 13782 Tenofovir Alafenamide Taf Medchemexpress, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hy 13782 tenofovir alafenamide taf medchemexpress/product/MedChemExpress
    Average 93 stars, based on 9 article reviews
    hy 13782 tenofovir alafenamide taf medchemexpress - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    MedChemExpress hy 13782 tenofovir alafenamide taf medchemexpress
    Hy 13782 Tenofovir Alafenamide Taf Medchemexpress, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hy 13782 tenofovir alafenamide taf medchemexpress/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    hy 13782 tenofovir alafenamide taf medchemexpress - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology santa cruz sc
    Santa Cruz Sc, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/santa cruz sc/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    santa cruz sc - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology α taf4
    DNA binding of TBP homologs is independent of core domain conservation. ( A ) Gene browser tracks at Gapdh for α-HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control (Ctrl, DMSO) or indole-3-acetic acid (500 μM, IAA)-treated mESCs. Alternative promoters are indicated. ( B ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol II occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all RNA Pol II genes. ( C ) Gene browser tracks at tRNA109-TyrGTA and tRNA110-AlaAGC for HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control or IAA-treated mESCs. ( D ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol III occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all tRNA genes. ( E ) Normalized read counts of IAA-treated HA-yTBP CUT&Tag signal versus IAA-treated HA-mTBP in the promoter (–250 to TSS) region of each Pol II (top) gene and in the gene body of each Pol III (bottom) gene are displayed as scatter plots. ( F ) Co-IP using α-HA or IgG for cells expressing HA-mTBP (left) or HA-yTBP (right) and blotted with α-HA, <t>α-TAF4,</t> and α-BRF1.
    α Taf4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/α taf4/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    α taf4 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    96
    Gilead Sciences oral f taf
    DNA binding of TBP homologs is independent of core domain conservation. ( A ) Gene browser tracks at Gapdh for α-HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control (Ctrl, DMSO) or indole-3-acetic acid (500 μM, IAA)-treated mESCs. Alternative promoters are indicated. ( B ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol II occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all RNA Pol II genes. ( C ) Gene browser tracks at tRNA109-TyrGTA and tRNA110-AlaAGC for HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control or IAA-treated mESCs. ( D ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol III occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all tRNA genes. ( E ) Normalized read counts of IAA-treated HA-yTBP CUT&Tag signal versus IAA-treated HA-mTBP in the promoter (–250 to TSS) region of each Pol II (top) gene and in the gene body of each Pol III (bottom) gene are displayed as scatter plots. ( F ) Co-IP using α-HA or IgG for cells expressing HA-mTBP (left) or HA-yTBP (right) and blotted with α-HA, <t>α-TAF4,</t> and α-BRF1.
    Oral F Taf, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/oral f taf/product/Gilead Sciences
    Average 96 stars, based on 1 article reviews
    oral f taf - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    Janssen drv 800 mg/cobi 150 mg/ftc 200 mg/taf tablet
    DNA binding of TBP homologs is independent of core domain conservation. ( A ) Gene browser tracks at Gapdh for α-HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control (Ctrl, DMSO) or indole-3-acetic acid (500 μM, IAA)-treated mESCs. Alternative promoters are indicated. ( B ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol II occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all RNA Pol II genes. ( C ) Gene browser tracks at tRNA109-TyrGTA and tRNA110-AlaAGC for HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control or IAA-treated mESCs. ( D ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol III occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all tRNA genes. ( E ) Normalized read counts of IAA-treated HA-yTBP CUT&Tag signal versus IAA-treated HA-mTBP in the promoter (–250 to TSS) region of each Pol II (top) gene and in the gene body of each Pol III (bottom) gene are displayed as scatter plots. ( F ) Co-IP using α-HA or IgG for cells expressing HA-mTBP (left) or HA-yTBP (right) and blotted with α-HA, <t>α-TAF4,</t> and α-BRF1.
    Drv 800 Mg/Cobi 150 Mg/Ftc 200 Mg/Taf Tablet, supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/drv 800 mg/cobi 150 mg/ftc 200 mg/taf tablet/product/Janssen
    Average 90 stars, based on 1 article reviews
    drv 800 mg/cobi 150 mg/ftc 200 mg/taf tablet - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    92
    Proteintech proteintech 55201 1 ap ppp2r1a
    DNA binding of TBP homologs is independent of core domain conservation. ( A ) Gene browser tracks at Gapdh for α-HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control (Ctrl, DMSO) or indole-3-acetic acid (500 μM, IAA)-treated mESCs. Alternative promoters are indicated. ( B ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol II occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all RNA Pol II genes. ( C ) Gene browser tracks at tRNA109-TyrGTA and tRNA110-AlaAGC for HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control or IAA-treated mESCs. ( D ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol III occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all tRNA genes. ( E ) Normalized read counts of IAA-treated HA-yTBP CUT&Tag signal versus IAA-treated HA-mTBP in the promoter (–250 to TSS) region of each Pol II (top) gene and in the gene body of each Pol III (bottom) gene are displayed as scatter plots. ( F ) Co-IP using α-HA or IgG for cells expressing HA-mTBP (left) or HA-yTBP (right) and blotted with α-HA, <t>α-TAF4,</t> and α-BRF1.
    Proteintech 55201 1 Ap Ppp2r1a, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteintech 55201 1 ap ppp2r1a/product/Proteintech
    Average 92 stars, based on 1 article reviews
    proteintech 55201 1 ap ppp2r1a - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    90
    Gilead Sciences bictegravir/emtricitabine/tenofovir alafenamide (bic/ftc/taf) lowdose formulation (30/120/15)
    DNA binding of TBP homologs is independent of core domain conservation. ( A ) Gene browser tracks at Gapdh for α-HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control (Ctrl, DMSO) or indole-3-acetic acid (500 μM, IAA)-treated mESCs. Alternative promoters are indicated. ( B ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol II occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all RNA Pol II genes. ( C ) Gene browser tracks at tRNA109-TyrGTA and tRNA110-AlaAGC for HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control or IAA-treated mESCs. ( D ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol III occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all tRNA genes. ( E ) Normalized read counts of IAA-treated HA-yTBP CUT&Tag signal versus IAA-treated HA-mTBP in the promoter (–250 to TSS) region of each Pol II (top) gene and in the gene body of each Pol III (bottom) gene are displayed as scatter plots. ( F ) Co-IP using α-HA or IgG for cells expressing HA-mTBP (left) or HA-yTBP (right) and blotted with α-HA, <t>α-TAF4,</t> and α-BRF1.
    Bictegravir/Emtricitabine/Tenofovir Alafenamide (Bic/Ftc/Taf) Lowdose Formulation (30/120/15), supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bictegravir/emtricitabine/tenofovir alafenamide (bic/ftc/taf) lowdose formulation (30/120/15)/product/Gilead Sciences
    Average 90 stars, based on 1 article reviews
    bictegravir/emtricitabine/tenofovir alafenamide (bic/ftc/taf) lowdose formulation (30/120/15) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Gilead Sciences tenofovir alafenamide (taf)
    DNA binding of TBP homologs is independent of core domain conservation. ( A ) Gene browser tracks at Gapdh for α-HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control (Ctrl, DMSO) or indole-3-acetic acid (500 μM, IAA)-treated mESCs. Alternative promoters are indicated. ( B ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol II occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all RNA Pol II genes. ( C ) Gene browser tracks at tRNA109-TyrGTA and tRNA110-AlaAGC for HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control or IAA-treated mESCs. ( D ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol III occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all tRNA genes. ( E ) Normalized read counts of IAA-treated HA-yTBP CUT&Tag signal versus IAA-treated HA-mTBP in the promoter (–250 to TSS) region of each Pol II (top) gene and in the gene body of each Pol III (bottom) gene are displayed as scatter plots. ( F ) Co-IP using α-HA or IgG for cells expressing HA-mTBP (left) or HA-yTBP (right) and blotted with α-HA, <t>α-TAF4,</t> and α-BRF1.
    Tenofovir Alafenamide (Taf), supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tenofovir alafenamide (taf)/product/Gilead Sciences
    Average 90 stars, based on 1 article reviews
    tenofovir alafenamide (taf) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    96
    Gilead Sciences f taf
    DNA binding of TBP homologs is independent of core domain conservation. ( A ) Gene browser tracks at Gapdh for α-HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control (Ctrl, DMSO) or indole-3-acetic acid (500 μM, IAA)-treated mESCs. Alternative promoters are indicated. ( B ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol II occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all RNA Pol II genes. ( C ) Gene browser tracks at tRNA109-TyrGTA and tRNA110-AlaAGC for HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control or IAA-treated mESCs. ( D ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol III occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all tRNA genes. ( E ) Normalized read counts of IAA-treated HA-yTBP CUT&Tag signal versus IAA-treated HA-mTBP in the promoter (–250 to TSS) region of each Pol II (top) gene and in the gene body of each Pol III (bottom) gene are displayed as scatter plots. ( F ) Co-IP using α-HA or IgG for cells expressing HA-mTBP (left) or HA-yTBP (right) and blotted with α-HA, <t>α-TAF4,</t> and α-BRF1.
    F Taf, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/f taf/product/Gilead Sciences
    Average 96 stars, based on 1 article reviews
    f taf - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    Image Search Results


    DNA binding of TBP homologs is independent of core domain conservation. ( A ) Gene browser tracks at Gapdh for α-HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control (Ctrl, DMSO) or indole-3-acetic acid (500 μM, IAA)-treated mESCs. Alternative promoters are indicated. ( B ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol II occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all RNA Pol II genes. ( C ) Gene browser tracks at tRNA109-TyrGTA and tRNA110-AlaAGC for HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control or IAA-treated mESCs. ( D ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol III occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all tRNA genes. ( E ) Normalized read counts of IAA-treated HA-yTBP CUT&Tag signal versus IAA-treated HA-mTBP in the promoter (–250 to TSS) region of each Pol II (top) gene and in the gene body of each Pol III (bottom) gene are displayed as scatter plots. ( F ) Co-IP using α-HA or IgG for cells expressing HA-mTBP (left) or HA-yTBP (right) and blotted with α-HA, α-TAF4, and α-BRF1.

    Journal: Nucleic Acids Research

    Article Title: Functional divergence of TBP homologs through distinct DNA-binding dynamics

    doi: 10.1093/nar/gkaf436

    Figure Lengend Snippet: DNA binding of TBP homologs is independent of core domain conservation. ( A ) Gene browser tracks at Gapdh for α-HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control (Ctrl, DMSO) or indole-3-acetic acid (500 μM, IAA)-treated mESCs. Alternative promoters are indicated. ( B ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol II occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all RNA Pol II genes. ( C ) Gene browser tracks at tRNA109-TyrGTA and tRNA110-AlaAGC for HA CUT&Tag of TRF2-HA, TRF3-HA, HA-mTBP, and HA-yTBP in control or IAA-treated mESCs. ( D ) Genome-wide average plots (top) and heatmaps (bottom) arranged by decreasing Pol III occupancy of HA CUT&Tag for TRF2-HA (Ctrl versus IAA), TRF3-HA (Ctrl versus IAA), HA-mTBP (IAA), and HA-yTBP (IAA) in a 2 kb window surrounding the TSS of all tRNA genes. ( E ) Normalized read counts of IAA-treated HA-yTBP CUT&Tag signal versus IAA-treated HA-mTBP in the promoter (–250 to TSS) region of each Pol II (top) gene and in the gene body of each Pol III (bottom) gene are displayed as scatter plots. ( F ) Co-IP using α-HA or IgG for cells expressing HA-mTBP (left) or HA-yTBP (right) and blotted with α-HA, α-TAF4, and α-BRF1.

    Article Snippet: Primary antibodies: anti-HA (α-HA) 1:5000 (EpiCypher 13-2010), α-Tubulin 1:7000 (Abcam ab6046), α-TAF4 1:5000 (Santa Cruz sc-136093), α-BRF1 1:1000 (Santa Cruz sc-390821), α-H3.3 1:5000 (Abnova H3F3B M01), α-Halo 1:3000 (Promega G9211), α-Flag 1:5000 (Sigma M2) α-TBP 1:3000 (mAbcam51841).

    Techniques: Binding Assay, Control, Genome Wide, Co-Immunoprecipitation Assay, Expressing